NCT00293397View on ClinicalTrials.gov

Chemoembolization Using Doxorubicin in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
Liver Cancer
Interventions
DEVICE

Drug-eluting beads loaded with doxorubicin hydrochloride

Doxorubicin eluting beads

Trial Locations (1)

21231-2410

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Yale University

OTHER

NCT00293397 - Chemoembolization Using Doxorubicin in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery | Biotech Hunter | Biotech Hunter